J-P Valentin

Moving towards better predictors of drug‐induced torsades de pointes

P. Sager, J. Valentin, A. Bass, 2008, British journal of pharmacology.

An in silico canine cardiac midmyocardial action potential duration model as a tool for early drug safety assessment.

H. Mistry, J. Valentin, C. Pollard, 2012, American journal of physiology. Heart and circulatory physiology.

Comparison of electrocardiographic analysis for risk of QT interval prolongation using safety pharmacology and toxicological studies.

M Markert, J. Valentin, A. Bass, 2009, Journal of pharmacological and toxicological methods.

Strategies to reduce the risk of drug‐induced QT interval prolongation: a pharmaceutical company perspective

J. Valentin, C. Pollard, T. Hammond, 2008, British journal of pharmacology.

Optimisation and validation of a medium-throughput electrophysiology-based hNav1.5 assay using IonWorks.

J-P Valentin, C E Pollard, N Abi-Gerges, 2008, Journal of pharmacological and toxicological methods.

Optimisation and validation of a medium-throughput electrophysiology-based hERG assay using IonWorks HT.

B. Small, E. Sullivan, J. Valentin, 2006, Journal of pharmacological and toxicological methods.

A Rabbit Langendorff Heart Proarrhythmia Model: Predictive Value for Clinical Identification of Torsades de Pointes

J. Valentin, C. Lawrence, C. Pollard, 2006, British journal of pharmacology.

Pharmacological validation of a semi-automated in vitro hippocampal brain slice assay for assessment of seizure liability.

T. Sharp, J. Valentin, A. Easter, 2007, Journal of pharmacological and toxicological methods.

On the relationship between block of the cardiac Na+ channel and drug‐induced prolongation of the QRS complex

J. Valentin, J-P Valentin, C E Pollard, 2011, British journal of pharmacology.